Vimarsana
Biggest News Aggregation in the World

Page 42 - Current Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Report Today - Breaking & Trending Today

XTB S A : CR no. 10/2024 – Information on the resolution of the Extraordinary General Meeting of XTB S.A. convened on 12 April 2024 - Vimarsana News

XTB S A : CR no. 10/2024 – Information on the resolution of the Extraordinary General Meeting of XTB S.A. convened on 12 April 2024

XTB S.A. DISCLAIMER This document is an unofficial translation of the Polish version of Current Report No. 10 dated...

JPMorgan Chase : JPMC&Co. Form 8-K 1Q2024 earnings release (12 April 2024) -April 12, 2024 at 07:42 am EDT - Vimarsana News

JPMorgan Chase : JPMC&Co. Form 8-K 1Q2024 earnings release (12 April 2024) -April 12, 2024 at 07:42 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ...

XTB S A : CR no. 12/2024 – Commencement of share buy-back programme - Vimarsana News

XTB S A : CR no. 12/2024 – Commencement of share buy-back programme

XTB S.A. DISCLAIMER This document is an unofficial translation of the Polish version of Current Report No. 12 dated...

JPMC&Co. 8-K (1Q2024); JPMC&Co. 2024 Proxy Stmt. | Company Announcement - Vimarsana News

JPMC&Co. 8-K (1Q2024); JPMC&Co. 2024 Proxy Stmt. | Company Announcement

Investegate announcements from JPMC&Co. 8-K (1Q2024); JPMC&Co. 2024 Proxy Stmt.

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA - Vimarsana News

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

NEW YORK, April 12, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton at...